We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$298B
AUM Growth
+$23.2B
Cap. Flow
+$26.9B
Cap. Flow %
9.01%
Top 10 Hldgs %
23.64%
Holding
11,380
New
1,223
Increased
4,885
Reduced
3,876
Closed
1,294

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.58B
2
NFLX icon
Netflix
NFLX
+$496M
3
META icon
Meta Platforms (Facebook)
META
+$275M
4
BABA icon
Alibaba
BABA
+$215M
5
UNH icon
UnitedHealth
UNH
+$189M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$926M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$682M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$556M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$246M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$235M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.18%
2 Technology 2.09%
3 Communication Services 1.44%
4 Financials 1.21%
5 Healthcare 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OIBR.C
9951
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$14K ﹤0.01%
+12,417
New +$19.4K
NDRA icon
9952
ENDRA Life Sciences
NDRA
$7.12M
– –
0
– –
ZVRA icon
9953
CALL
Zevra Therapeutics
ZVRA
$715M
$13K ﹤0.01%
1,156
+487
+73% +$8.8K
BIOC
9954
DELISTED
Biocept, Inc.
BIOC
$13K ﹤0.01%
+55
New +$15.8K
UUUU.WS
9955
DELISTED
Energy Fuels Inc.
UUUU.WS
$13K ﹤0.01%
18,831
-2,193
-10% -$1.74K
NAVB
9956
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$13K ﹤0.01%
+18,200
New +$11.2K
APVO icon
9957
Aptevo Therapeutics
APVO
$4.43M
– –
0
– –
CATX icon
9958
Perspective Therapeutics
CATX
$376M
$12K ﹤0.01%
3,844
+2,267
+144% +$8.21K
CENN icon
9959
Cenntro
CENN
$10.1M
– –
0
– –
FCEL icon
9960
FuelCell Energy
FCEL
$1.54B
$12K ﹤0.01%
1,198
-5,368
-82% -$63.6K
HDSN
9961
PUT
Hudson Technologies
HDSN
$230M
$12K ﹤0.01%
17,200
+700
+4% +$434
LCTX icon
9962
PUT
Lineage Cell Therapeutics
LCTX
$286M
$12K ﹤0.01%
12,700
-5,100
-29% -$5.28K
UAMY icon
9963
United States Antimony
UAMY
$778M
$12K ﹤0.01%
+20,842
New +$13.5K
BLCM
9964
PUT
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$12K ﹤0.01%
1,100
-900
-45% -$11.8K
TYME
9965
PUT
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$12K ﹤0.01%
+10,100
New +$12.7K
TIO
9966
DELISTED
Tingo Group, Inc. Common Stock
TIO
$12K ﹤0.01%
22,117
+7,000
+46% +$4.67K
BSQR
9967
DELISTED
BSQUARE Corporation
BSQR
$12K ﹤0.01%
10,260
-28,942
-74% -$36K
TWLVW
9968
DELISTED
Twelve Seas Investment Company Warrant
TWLVW
$12K ﹤0.01%
38,788
+18,802
+94% +$5.82K
ACRS icon
9969
PUT
Aclaris Therapeutics
ACRS
$963M
$11K ﹤0.01%
10,300
-36,200
-78% -$51.4K
TULP
9970
Bloomia Holdings
TULP
$15.3M
$11K ﹤0.01%
+1,617
New +$11.5K
TNXP icon
9971
Tonix Pharmaceuticals
TNXP
$234M
– –
0
– –
TOVX icon
9972
Theriva Biologics
TOVX
$10.9M
$11K ﹤0.01%
100
+60
+150% +$7.25K
INFI
9973
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$11K ﹤0.01%
+10,700
New +$14.6K
BLCM
9974
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$11K ﹤0.01%
1,054
-23,736
-96% -$310K
SRRA
9975
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$11K ﹤0.01%
+674
New +$12.9K
397 398
399
400 401

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q3 2019 Portfolio in Review

As of Q3 2019, Jeff Yass held 11,380 positions worth $298B, up 8.4% from $275B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $26.9B of net new capital in Q3 2019, opening 1,223 new positions and adding to 4,885 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 1.8% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $926M trimmed.

  • Jeff Yass's largest Q3 2019 buy was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
  • Jeff Yass added most to Amazon in Q3 2019, an estimated $1.58B increase.
  • Jeff Yass's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $926M.
  • Jeff Yass fully exited Tableau Software, Inc. in Q3 2019, selling an estimated $179M.
  • Jeff Yass's ten largest holdings make up 24% of its $298B portfolio in Q3 2019.
  • Jeff Yass opened 1,223 new positions and closed 1,294 in Q3 2019.
  • Jeff Yass's portfolio value rose 8.4% quarter-over-quarter to $298B.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.